Pharmaceuticals (367) | Bonus & Incentive Agreements (367)

Browse by Company

ACELRX PHARMACEUTICALS INC (4)
Acer Therapeutics Inc. (2)
Aclaris Therapeutics, Inc. (2)
Acreage Holdings, Inc. (2)
Adamis Pharmaceuticals Corp (3)
ALIMERA SCIENCES INC (5)
Amag Pharmaceuticals (8)
Amneal Pharmaceuticals, Inc. (3)
Ampio Pharmaceuticals, Inc. (1)
ANI Pharma Inc (2)
ARVINAS, INC. (1)
Assertio Therapeutics, Inc (2)
AVADEL PHARMACEUTICALS PLC (2)
Axsome Therapeutics, Inc. (2)
Bakhu Holdings, Corp. (1)
Baudax Bio, Inc. (2)
Bausch Health Companies Inc. (5)
BIODELIVERY SCIENCES INTERNATIONAL INC (5)
BioPharmX Corp (2)
Bristol-Myers Squibb (41)
Canopy Growth Corp (1)
CASSAVA SCIENCES INC (1)
Catalent Inc (6)
Cerecor Inc. (2)
COLLEGIUM PHARMACEUTICAL, INC (1)
CorMedix Inc. (1)
Cronos Group Inc. (3)
CUMBERLAND PHARMACEUTICALS INC (2)
Cure Pharmaceutical Holding Corp. (4)
Elanco Animal Health Inc (7)
Endo International plc (13)
Eton Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (4)
Evolus, Inc. (1)
Exactus, Inc. (3)
EYENOVIA, INC. (2)
EyePoint Pharmaceuticals, Inc. (2)
Fulcrum Therapeutics, Inc. (6)
Green Thumb Industries Inc. (1)
GW PHARMACEUTICALS PLC (2)
Horizon Pharma plc (2)
IMARA Inc. (8)
INNOVATE BIOPHARMACEUTICALS, INC. (2)
Intra-Cellular Therapies, Inc. (5)
Jaguar Health, Inc. (1)
Jazz Pharmaceuticals plc (8)
Kala Pharmaceuticals, Inc. (3)
Kaleido Biosciences, Inc. (3)
Kannalife Inc (2)
KEMPHARM, INC (1)
Lilly (Eli) & Co. (6)
Liquidia Corp (2)
Lyra Therapeutics, Inc. (3)
Mallinckrodt (1)
MARINUS PHARMACEUTICALS INC (2)
Medicine Man Technologies, Inc. (2)
Menlo Therapeutics Inc. (6)
Merck (2)
Milestone Pharmaceuticals Inc. (5)
Mylan N.V. (5)
Nabriva Therapeutics plc (8)
NEKTAR THERAPEUTICS (2)
NGM BIOPHARMACEUTICALS INC (3)
NovaBay Pharmaceuticals, Inc. (2)
Novan, Inc. (2)
OCULAR THERAPEUTIX, INC (2)
OMEROS CORP (1)
Onconova Therapeutics, Inc. (1)
OptiNose, Inc. (1)
Osmotica Pharmaceuticals plc (3)
Pacira Pharmaceuticals, Inc. (3)
Panacea Acquisition Corp (5)
Perrigo (15)
Pfizer (1)
Phathom Pharmaceuticals, Inc. (8)
PLIANT THERAPEUTICS, INC. (3)
Processa Pharmaceuticals, Inc. (2)
Pulmatrix, Inc. (1)
QUANTA INC (1)
REATA PHARMACEUTICALS INC (1)
Recro Pharma, Inc. (1)
RELMADA THERAPEUTICS, INC. (3)
RespireRx Pharmaceuticals Inc. (8)
resTORbio, Inc. (13)
Revance Therapeutics, Inc. (4)
Royalty Pharma plc (2)
Satsuma Pharmaceuticals, Inc. (7)
Scopus BioPharma Inc. (2)
SCYNEXIS INC (1)
SenesTech, Inc. (1)
Supernus Pharmaceuticals, Inc. (2)
Tenzing Acquisition Corp. (4)
Terra Tech Corp. (2)
TEVA PHARMACEUTICAL INDUSTRIES LTD (4)
TFF Pharmaceuticals, Inc. (1)
TITAN PHARMACEUTICALS INC (1)
Trevi Therapeutics, Inc. (4)
Tricida, Inc. (1)
Urovant Sciences Ltd. (2)
Vitality Biopharma, Inc. (1)
Wave Life Sciences Ltd. (4)
Wize Pharma, Inc. (5)
ZOGENIX, INC. (2)

Recent Contracts

Form of 2021 Performance-Based Restricted Share Unit Agreement under the 2014 Equity Incentive Plan, effective as of March 17, 2021 (Wave Life Sciences Ltd., Filed With SEC on May 13, 2021)
Form of Amended and Restated 2019 Performance-Based Restricted Share Unit Agreement under the 2014 Equity Incentive Plan, effective as of March 17, 2021 (Wave Life Sciences Ltd., Filed With SEC on May 13, 2021)
2021 Executive Annual Bonus Plan (Green Thumb Industries Inc., Filed With SEC on May 13, 2021)
Form of Stock Award Agreement under the Endo International plc Amended and Restated 2015 Stock Incentive Plan (Endo International plc, Filed With SEC on May 7, 2021)
Form of Performance Award Agreement under the Endo International plc Amended and Restated 2015 Stock Incentive Plan (Endo International plc, Filed With SEC on May 7, 2021)
Form of Long-Term Cash Award Agreement under the Endo International plc Amended and Restated 2015 Stock Incentive Plan (Endo International plc, Filed With SEC on May 7, 2021)
Form of Elanco Animal Health Incorporated Performance-Based Restricted Stock Unit Award Agreement for executives with respect to annual awards (Elanco Animal Health Inc, Filed With SEC on May 7, 2021)
Elanco Animal Health Incorporated Corporate Bonus Plan (Elanco Animal Health Inc, Filed With SEC on May 7, 2021)
Performance Restricted Stock Unit Award Agreement with Mr. Justin Hall (NovaBay Pharmaceuticals, Inc., Filed With SEC on May 6, 2021)
Form of Share Option Agreement under the 2021 Inducement Share Incentive Plan (Nabriva Therapeutics plc, Filed With SEC on May 6, 2021)